OBJECTIVES: To look for evidence of early ischaemic neurochemical changes in patients suffering severe traumatic brain injury (TBI) and severe subarachnoid haemorrhage (SAH). Proton metabolite concentrations were measured in normal and abnormal areas of brain on T2 MR imaging, in regions considered particularly vulnerable to ischaemic injury. METHODS: Intensive care patients underwent T2 weighted imaging in a 1.5 Tesla MR scanner and proton magnetic resonance spectroscopy (single voxel or chemical shift imaging). Metabolite values in areas that appeared 'normal' and 'abnormal' on T2 MR imaging were compared with those obtained from normal controls. RESULTS: 18 TBI and 6 SAH patients were imaged at 1 to 26 days. N-acetyl aspartate (NAA) was lower in TBI and SAH patients compared to controls in both T2 normal and T2 abnormal areas (p<0.0005). SAH, but not TBI patients also had increased choline and creatine compared to controls in the T2 normal (p<0.02, p<0.02 respectively) and T2 abnormal (p=0.0003, p=0.003) areas. No lactate was found in TBI or SAH patients. CONCLUSIONS: Significant loss of normal functioning neurones was present in TBI and SAH, but no evidence of anaerobic metabolism using lactate as a surrogate marker, questioning the role of 'ischemia' as a major mechanism of damage. Increased choline and creatine were found in SAH patients suggestive of increased cell-wall turnover. Current theories of brain injury after TBI or SAH do not explain these observed neurochemical changes and further research is required.
OBJECTIVES: To look for evidence of early ischaemic neurochemical changes in patients suffering severe traumatic brain injury (TBI) and severe subarachnoid haemorrhage (SAH). Proton metabolite concentrations were measured in normal and abnormal areas of brain on T2 MR imaging, in regions considered particularly vulnerable to ischaemic injury. METHODS: Intensive care patients underwent T2 weighted imaging in a 1.5 Tesla MR scanner and proton magnetic resonance spectroscopy (single voxel or chemical shift imaging). Metabolite values in areas that appeared 'normal' and 'abnormal' on T2 MR imaging were compared with those obtained from normal controls. RESULTS: 18 TBI and 6 SAHpatients were imaged at 1 to 26 days. N-acetyl aspartate (NAA) was lower in TBI and SAHpatients compared to controls in both T2 normal and T2 abnormal areas (p<0.0005). SAH, but not TBI patients also had increased choline and creatine compared to controls in the T2 normal (p<0.02, p<0.02 respectively) and T2 abnormal (p=0.0003, p=0.003) areas. No lactate was found in TBI or SAHpatients. CONCLUSIONS: Significant loss of normal functioning neurones was present in TBI and SAH, but no evidence of anaerobic metabolism using lactate as a surrogate marker, questioning the role of 'ischemia' as a major mechanism of damage. Increased choline and creatine were found in SAHpatients suggestive of increased cell-wall turnover. Current theories of brain injury after TBI or SAH do not explain these observed neurochemical changes and further research is required.
Authors: Jens O Heidenreich; Rüdiger Stendel; Mario Brock; Karl-Jürgen Wolf; Andreas M Schilling Journal: AJNR Am J Neuroradiol Date: 2005-02 Impact factor: 3.825
Authors: Stephen Ashwal; Karen A Tong; Nirmalya Ghosh; Brenda Bartnik-Olson; Barbara A Holshouser Journal: J Child Neurol Date: 2014-06-22 Impact factor: 1.987
Authors: Su Xu; Jiachen Zhuo; Jennifer Racz; Da Shi; Steven Roys; Gary Fiskum; Rao Gullapalli Journal: J Neurotrauma Date: 2011-09-29 Impact factor: 5.269
Authors: M Wagner; A Jurcoane; C Hildebrand; E Güresir; H Vatter; F E Zanella; J Berkefeld; U Pilatus; E Hattingen Journal: AJNR Am J Neuroradiol Date: 2013-02-22 Impact factor: 3.825
Authors: Varan Govind; Stuart Gold; Krithica Kaliannan; Gaurav Saigal; Steven Falcone; Kristopher L Arheart; Leo Harris; Jonathan Jagid; Andrew A Maudsley Journal: J Neurotrauma Date: 2010-03 Impact factor: 5.269
Authors: Varanavasi Govindaraju; Grant E Gauger; Geoffrey T Manley; Andreas Ebel; Michele Meeker; Andrew A Maudsley Journal: AJNR Am J Neuroradiol Date: 2004-05 Impact factor: 3.825